Unknown

Dataset Information

0

Adiponectin inhibits tumor necrosis factor-?-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation.


ABSTRACT: RATIONALE:Anti-inflammatory and vascular protective actions of adiponectin are well recognized. However, many fundamental questions remain unanswered. OBJECTIVE:The current study attempted to identify the adiponectin receptor subtype responsible for adiponectin's vascular protective action and investigate the role of ceramidase activation in adiponectin anti-inflammatory signaling. METHODS AND RESULTS:Adiponectin significantly reduced tumor necrosis factor (TNF)?-induced intercellular adhesion molecule-1 expression and attenuated TNF?-induced oxidative/nitrative stress in human umbilical vein endothelial cells. These anti-inflammatory actions were virtually abolished by adiponectin receptor 1 (AdipoR1-), but not AdipoR2-, knockdown (KD). Treatment with adiponectin significantly increased neutral ceramidase (nCDase) activity (3.7-fold; P<0.01). AdipoR1-KD markedly reduced globular adiponectin-induced nCDase activation, whereas AdipoR2-KD only slightly reduced. More importantly, small interfering RNA-mediated nCDase-KD markedly blocked the effect of adiponectin on TNF?-induced intercellular adhesion molecule-1 expression. AMP-activated protein kinase-KD failed to block adiponectin-induced nCDase activation and modestly inhibited adiponectin anti-inflammatory effect. In contrast, in caveolin-1 KD (Cav1-KD) cells, >87% of adiponectin-induced nCDase activation was lost. Whereas adiponectin treatment failed to inhibit TNF?-induced intercellular adhesion molecule-1 expression, treatment with sphingosine-1-phosphate or SEW (sphingosine-1-phosphate receptor agonist) remained effective in Cav1-KD cells. AdipoR1 and Cav1 colocalized and coprecipitated in human umbilical vein endothelial cells. Adiponectin treatment did not affect this interaction. There is weak basal Cav1/nCDase interaction, which significantly increased after adiponectin treatment. Knockout of AdipoR1 or Cav1 abolished the inhibitory effect of adiponectin on leukocyte rolling and adhesion in vivo. CONCLUSIONS:These results demonstrate for the first time that adiponectin inhibits TNF?-induced inflammatory response via Cav1-mediated ceramidase recruitment and activation in an AdipoR1-dependent fashion.

SUBMITTER: Wang Y 

PROVIDER: S-EPMC3961763 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation.

Wang Yajing Y   Wang Xiaoliang X   Lau Wayne Bond WB   Yuan Yuexing Y   Booth David D   Li Jing-Jing JJ   Scalia Rosario R   Preston Kyle K   Gao Erhe E   Koch Walter W   Ma Xin-Liang XL  

Circulation research 20140107 5


<h4>Rationale</h4>Anti-inflammatory and vascular protective actions of adiponectin are well recognized. However, many fundamental questions remain unanswered.<h4>Objective</h4>The current study attempted to identify the adiponectin receptor subtype responsible for adiponectin's vascular protective action and investigate the role of ceramidase activation in adiponectin anti-inflammatory signaling.<h4>Methods and results</h4>Adiponectin significantly reduced tumor necrosis factor (TNF)α-induced in  ...[more]

Similar Datasets

| S-EPMC3134999 | biostudies-literature
| S-EPMC3448099 | biostudies-literature
| S-EPMC5595237 | biostudies-other
| S-EPMC6180945 | biostudies-literature
| S-EPMC9758717 | biostudies-literature
| S-EPMC5672041 | biostudies-literature
| S-EPMC10067764 | biostudies-literature
| S-EPMC5931493 | biostudies-literature
| S-EPMC2515087 | biostudies-literature
| S-EPMC6455290 | biostudies-literature